This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of GLEEVEC (imatinib mesylate) tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the GLEEVEC (imatinib mesylate) tablets medicine cost price in India.
The order for GLEEVEC (imatinib mesylate) tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Imatinib, sold under the brand names Gleevec among others, is a medication used to treat cancer. Specifically, it is used for chronic myelogenous leukemia (CML) and acute lymphocytic leukemia (ALL) that are Philadelphia chromosome-positive (Ph+), certain types of gastrointestinal stromal tumors (GIST), hypereosinophilic syndrome (HES), chronic eosinophilic leukemia (CEL), systemic mastocytosis, and myelodysplastic syndrome.
GLEEVEC (imatinib mesylate) tablets for oral use Initial U.S. Approval: 2001
Generic Name: imatinib mesylate
Tablets (scored): 100 mg and 400 mg.
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand GLEEVEC (imatinib mesylate) tablets on prescription and Import License in Patient's Name only.
For overseas patients, GLEEVEC (imatinib mesylate) tablets can be made available in Send your enquiry to find GLEEVEC (imatinib mesylate) tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For GLEEVEC (imatinib mesylate) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Lupin in alliance with Natco receives FDA approval for Imatinib Mesylate Tablets For More Details
First Generic Version of Gleevec Approved by FDA For More Details